Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-24-068773

Chief Medical Officer gave up 1,982 shares (to pay taxes)

  • Chief Medical Officer acquired 3,906 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer 2024-06-03 Option exercise +3,906 46,468 D
GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer 2024-06-03 Shares withheld for taxes −1,982 $8.37 $16,589 44,486 D
Derivatives
GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer 2024-06-03 Option exercise · Restricted Stock Units −3,906 27,346 D
Loading xslF345X05/tm2416581-3_4seq1.xml…